Latest Features & Opinion

Live Coverage of AAN 2017

Stay with Neurology Advisor for live coverage of the 69th annual meeting of the American Academy of Neurology in Boston, MA.

Migraine Across Female Reproductive Stages

The characteristics of migraine may change throughout a woman's reproductive stages, and may require different treatment strategies.

Transitioning Pediatric Patients to Adult Care

The transition process can be challenging for patients and families, requiring a great deal of preplanning by providers.

Epilepsy Classification System Updated

The International League Against Epilepsy has revised its epilepsy classification system in an effort to inform epilepsy research and aid drug development.

Updated Diabetic Neuropathy Guidelines

New evidence on diabetic neuropathy has emerged since the ADA's last published a position statement in 2005.

Understanding Cogniphobia in Migraine

Future research should focus on whether cogniphobia can be a modifiable factor in the treatment of patients with migraine.

Depression in Epilepsy: Detection and Treatment

There are several drug-based and non-pharmacological treatments available that can help reduce symptoms of depression in patients with epilepsy.

Gender Disparities in Concussion Diagnosis, Treatment

Female athletes face a greater incidence of and longer recovery time from concussion compared with males.
Concerns Arise Over Reporting of Negative Clinical Trial Data

Concerns Arise Over Reporting of Negative Clinical Trial Data

The main objection to nonreporting of negative results is that it contributes to a body of knowledge that is at best, incomplete, and at worst, wrong.

General Neurology

Patient Advocacy Groups and Conflict of Interest: Should You Be Wary?

Patient Advocacy Groups and Conflict of Interest: Should You Be Wary?

A survey showed 67.3% of patient advocacy organizations received industry funding, while 11.9% received more than half of their funding from industry.

Drug Lookup

Search our drug information database which contains an extensive list of neurologic drugs.

Browse drugs by:

Brand Generic Disease

Latest in Autism Spectrum Disorder

FDA Warns of Reported Autism Treatments, Cures

The FDA has warned and/or taken action against a number of companies that have made improper claims about the intended use of their products to treat or cure autism.

Autism Linked to Sex-Specific Brain Structure

Female participants with phenotypic male neuroanatomical features had an increased risk for autism spectrum disorder.

Autism Diagnosis and Treatment Often Delayed

Despite increased awareness, barriers to earlier diagnosis of autism spectrum disorder still persist.

Latest in Neuromuscular Disorders

RENEW Trial: Promising Results for Optic Neuritis Treatment

Opicinumab may potentially enhance spontaneous remyelination after acute optic neuritis.

FDA Approves Duchenne Muscular Dystrophy Drug

Emflaza is approved for the treatment of Duchenne muscular dystrophy regardless of genetic etiology.

Alexion Seeking New Indication for Myasthenia Gravis Drug

Soliris is currently approved to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).

Sign Up for Free e-newsletters